FGF23 and hydrops fetalis: Higher levels of FGF-23 were associated with volume overload, more frequent failure in reaching optimal doses of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, and increased all-cause mortality and HF hospitalizations [23].